ADMA Biologics (ADMA) Reports Q4 Loss of $0.58

ADMA Biologics (NASDAQ: ADMA) reported Q4 EPS of ($0.58), versus $0.50 reported last year. Revenue for the quarter came in at $524 thousand, versus $30 million reported last year.

For earnings history and earnings-related data on ADMA Biologics (ADMA) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Jefferies Starts DBS Group Holdings (DBS:SP) (DBSDY) at Buy
• HP shares slide as tech giant forecasts 2027 PC market slump